We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Elevated Homocysteine Linked to Form of Stroke

By Biotechdaily staff writers
Posted on 21 May 2002
A study headed by Dr. More...
Allesandro Pezzini of the University of Brescia (Italy) has found a direct link between elevated blood levels of homocysteine and a form of stroke called spontaneous cervical artery dissection (sCAD).

Cervical artery dissection (CAD) occurs when the artery from the heart to the brain is cut or torn, allowing blood to rush into the artery lining. Blood clots that form as the body responds to the injury can break away, clogging the artery and causing a stroke. CAD is estimated to cause 20% of ischemic strokes in people under age 45. The major symptom is sudden, excruciating pain on one side of the neck. Although it can be caused by trauma, such as being in an automobile accident, more than half the time it is spontaneous, meaning no trauma can be found.

While sCAD has no obvious traumatic cause, the current study, which appears in the March 2002 issue of Stroke, found that people with elevated blood levels of homocysteine were significantly more represented in the group of patients with sCAD than stroke-free control subjects (64% vs. 13.9%). In addition, those with sCAD were also three times more likely to have two copies of the "T” version of the C677T MTHFR gene (36% vs. 11%), leading researchers to suspect homocysteine's role may be genetic.

Epidemiologic studies have shown that elevated levels of homocysteine in the blood are related to a higher risk of coronary heart disease, stroke and peripheral vascular disease. Some evidence suggests that homocysteine may have an effect on atherosclerosis by damaging the inner lining of arteries and promoting blood clots, but a direct causal link has not been established. Blood levels of homocysteine are strongly influenced by diet and genetic factors.

"Increased blood concentration of homocysteine seems to predispose individuals to sCAD,” says Dr. Pezzini. "Our data also suggest that genetic abnormalities in homocysteine metabolism may be a factor.”


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.